Medicus Pharma Announces Phase 2 Trial Update Webcast With Lead Investigator | NewsOut
Biotech and healthcare investors: Medicus Pharma announced that renowned academic dermatologist Dr. Babar Rao, principal investigator of the SKN-JCT-003 Phase 2 clinical trial, will participate in the company’s upcoming business update webcast.
Reporting from the New York Stock Exchange, Jane King explains the randomized, double-blind Phase 2 study is designed to evaluate the therapeutic contribution of doxorubicin in the company’s novel treatment program, with further insights expected during the March 26 investor webcast.
#MedicusPharma
#ClinicalTrials
#BiotechNews
#DermatologyResearch
#Doxorubicin
#DrugDevelopment
#HealthcareInnovation
#LifeSciences
#CancerResearch
#HealthcareInvesting
#JaneKing
#NewsOut
